Related Articles
Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway
Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer
TP53 upregulates α‑smooth muscle actin expression in tamoxifen‑resistant breast cancer cells
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
Prognostic significance of tumour‑infiltrating lymphocytes for oestrogen receptor‑negative breast cancer without lymph node metastasis